...
首页> 外文期刊>Cytogenetic and genome research >A de novo 1q22q23.1 Interstitial Microdeletion in a Girl with Intellectual Disability and Multiple Congenital Anomalies Including Congenital Heart Defect
【24h】

A de novo 1q22q23.1 Interstitial Microdeletion in a Girl with Intellectual Disability and Multiple Congenital Anomalies Including Congenital Heart Defect

机译:识别智者残疾女孩中的德诺伊1季度1Q22Q23231.1患有智力障碍的女孩和包括先天性心脏缺陷的多个先天性异常

获取原文
获取原文并翻译 | 示例

摘要

Many studies have shown that molecular karyotyping is an effective diagnostic tool in individuals with developmental delay/intellectual disability. We report on a de novo interstitial 1q22q23.1 microdeletion, 1.6 Mb in size, detected in a patient with short stature, microcephaly, hypoplastic corpus callosum, cleft palate, minor facial anomalies, congenital heart defect, camptodactyly of the 4-5th fingers, and intellectual disability. Chromosomal microarray analysis revealed a 1.6-Mb deletion in the 1q22q23.1 region, arr[GRCh37] 1q22q23.1(155630752_157193893)×1. Real-time PCR analysis confirmed its de novo origin. The deleted region encompasses 50 protein-coding genes, including the morbid genes APOA1BP , ARHGEF2 , LAMTOR2 , LMNA , NTRK1 , PRCC , RIT1 , SEMA4A , and YY1AP1 . Although the unique phenotype observed in our patient can arise from the haploinsufficiency of the dosage-sensitive LMNA gene, the dosage imbalance of other genes implicated in the rearrangement could also contribute to the phenotype. Further studies are required for the delineation of the phenotype associated with this rare chromosomal alteration and elucidation of the critical genes for manifestation of the specific clinical features.
机译:许多研究表明,分子核型化是具有发育延迟/智力残疾的个体的有效诊断工具。我们报告DE Novo Intertitial 1Q22CTiens 1Q223.1微缺,1.6 MB的大小,在患者身材患者中检测到,微微术,软糖胼callosum,腭裂,次要面部异常,先天性心脏缺损,4-5个手指的患者,和智力残疾。染色体微阵列分析显示1Q22Q23.1区,ARR [GRCH37] 1Q22Q23.1(155630752_157193893)×1中的1.6mb缺失。实时PCR分析证实了其De Novo起源。缺失的区域包括50个蛋白质编码基因,包括病态基因apoa1bp,arhgef2,lamtor2,lmna,ntrk1,prcc,rit1,sema4a和Yy1ap1。尽管在我们患者中观察到的独特表型可以从剂量敏感的LMNA基因的单量水能中出现,但是在重新排列中牵连的其他基因的剂量不平衡也可能有助于表型。划分与这种稀有染色体改变相关的表型并阐明临界基因的表现,需要进一步的研究,以表现特定的临床特征。

著录项

相似文献

  • 外文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号